The approval is for the intravenous use of the Azedra injection in patients whose adrenal gland tumors are unresectable and have spread beyond the original tumor site and
The post Progenics’ Azedra gets FDA approval for rare adrenal gland tumors appeared first on Pharma Business review.
Original Article: Progenics’ Azedra gets FDA approval for rare adrenal gland tumors